Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Bookman

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Cell|October 21, 1988
The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lckA Veillette, M A Bookman, E M Horak, et al.
The American Journal of Surgical Pathology|August 1, 1990
Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlationsP Lardelli, M A Bookman, J Sundeen, et al.
American Journal of Clinical Oncology|February 1, 1996
A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group StudyK Y Look, J A Blessing, M D Adelson, et al.
Seminars in Oncology|January 14, 1998
Intravenous prophylaxis for paclitaxel-related hypersensitivity reactionsM A Bookman, D D Kloth, P E Kover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactionsM A Bookman, D D Kloth, P E Kover, et al.
Gynecologic Oncology|June 1, 2000
Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology GroupM A Bookman, J A Blessing, P Hanjani, et al.
Nature|March 16, 1989
Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lckA Veillette, M A Bookman, E M Horak, et al.
Molecular and Cellular Biology|October 1, 1988
Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activationA Veillette, I D Horak, E M Horak, et al.
Journal of the National Cancer Institute|May 2, 1990
Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factorsM A Bookman, P Lardelli, E S Jaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group StudyW P McGuire, J A Blessing, M A Bookman, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Cell|October 21, 1988
The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lckA Veillette, M A Bookman, E M Horak, et al.
The American Journal of Surgical Pathology|August 1, 1990
Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlationsP Lardelli, M A Bookman, J Sundeen, et al.
American Journal of Clinical Oncology|February 1, 1996
A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group StudyK Y Look, J A Blessing, M D Adelson, et al.
Seminars in Oncology|January 14, 1998
Intravenous prophylaxis for paclitaxel-related hypersensitivity reactionsM A Bookman, D D Kloth, P E Kover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactionsM A Bookman, D D Kloth, P E Kover, et al.
Gynecologic Oncology|June 1, 2000
Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology GroupM A Bookman, J A Blessing, P Hanjani, et al.
Nature|March 16, 1989
Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lckA Veillette, M A Bookman, E M Horak, et al.
Molecular and Cellular Biology|October 1, 1988
Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activationA Veillette, I D Horak, E M Horak, et al.
Journal of the National Cancer Institute|May 2, 1990
Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factorsM A Bookman, P Lardelli, E S Jaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group StudyW P McGuire, J A Blessing, M A Bookman, et al.
Pageof 8